 |
|---|
| As Of | Filer | Filing¹ | For·On·As | Docs:Size | Issuer | | Filing Agent | | | | | | | | | |
|---|
|
|---|
4/24/24 Austin Mark John 4 Officer² 1:6K Perspective Therapeutics, Inc. Donnelley … Solutions/FA
4/19/24 Commodore Capital LP SC 13G 1:91K Perspective Therapeutics, Inc. M2 Compliance LLC/FA
4/18/24 Perspective Therapeutics, Inc. DEFA14A 1:1.3M Donnelley … Solutions/FA
4/18/24 Perspective Therapeutics, Inc. DEF 14A 4/18/24 1:1.8M Donnelley … Solutions/FA
4/16/24 Perspective Therapeutics, Inc. 8-K:2,9 4/12/24 9:1M Donnelley … Solutions/FA
4/9/24‡ Perspective Therapeutics, Inc. EFFECT 4/9/24 1:2K SEC #5
4/9/24 Perspective Therapeutics, Inc. 424B3 1:171K RDG Filings/FA
4/8/24 Perspective Therapeutics, Inc. CORRESP¶ 5/7/24 1:16K Donnelley … Solutions/FA
4/8/24 Perspective Therapeutics, Inc. PRE 14A 5/31/24 1:1.8M Donnelley … Solutions/FA
4/8/24 Perspective Therapeutics, Inc. 8-K:4,9 4/5/24 9:153K Donnelley … Solutions/FA
4/8/24 SEC UPLOAD¶ 5/7/24 2:40K Perspective Therapeutics, Inc.
4/3/24 Perspective Therapeutics, Inc. 8-K:1,9 3/28/24 12:180K RDG Filings/FA
4/1/24 Perspective Therapeutics, Inc. S-8 4/1/24 4:121K RDG Filings/FA
3/29/24 Perspective Therapeutics, Inc. S-3 4:280K RDG Filings/FA
3/28/24 Perspective Therapeutics, Inc. 10-K 12/31/23 111:13M RDG Filings/FA
3/28/24 Perspective Therapeutics, Inc. 8-K:2,9 3/28/24 12:366K RDG Filings/FA
3/25/24 Perspective Therapeutics, Inc. 8-K:8 3/25/24 11:152K RDG Filings/FA
3/19/24 Perspective Therapeutics, Inc. 8-K:8,9 3/18/24 13:6.8M RDG Filings/FA
3/18/24 Perspective Therapeutics, Inc. D 3/18/24 1:12K RDG Filings/FA
3/8/24 Lantheus Holdings, Inc. 4 10% Owner² 1:6K Perspective Therapeutics, Inc. Donnelley … Solutions/FA
Lantheus Alpha Therapy, LLC
| ____________ | | ‡ | A non-Insider-Ownership Filing that was accepted after the SEC “closed” at 5:30:00pm ET. The legal “Filed As Of” date may be the next, or another, day. | | ¹ | Filing/Form Types: | | 4 | Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 { The Filer is an Insider² of the Issuer }. | | 8-K | Current Report — Form 8-K { Item 1: Business & Operations; 2: Financial Info; 3: Securities & Trading; 4: Accountants & Accounting; 5: Governance & Management; 6: Asset-Backed Securities; 7: Disclosures; 8: Events; 9: Financials }. | | 10-K | Annual Report — Form 10-K. | | 424B3 | Prospectus – New Facts or Events. | | CORRESP | Comment-Response or Other Letter to the SEC. | | D | Notice of an Exempt Offering of Securities — Form D. | | DEF 14A | Definitive Proxy Statement — Schedule 14A. | | DEFA14A | Definitive Additional Proxy Soliciting Material — Schedule 14A. | | EFFECT | SEC Notice of Effectiveness. | | PRE 14A | Preliminary Proxy Statement — Schedule 14A. | | S-3 | Registration Statement – Securities for a Transaction — Form S-3. | | S-8 | Registration Statement – Securities for an Employee Benefit Plan — Form S-8. | | SC 13G | Statement of Acquisition of Beneficial Ownership by a “Passive” Investor — Schedule 13G. | | UPLOAD | Comment or Other Letter from the SEC. | | ¶ | This Filing contains a delayed-release Document. | | ² | Insider: The Filer is a Director, Officer, 10% Owner and/or Other “insider” of the Issuer. |
|
